Human Vaccines & Immunotherapeutics

Article	Citations
Human vaccines & immunotherapeutics: News October 2022	156
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China	107
Vaccine manufacturing is essential to ensure access	103
Response to a letter to the editor regarding ‘ the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka’	102
Human vaccines and immunotherapeutics: News December 2023	95
Uptake, adverse effect, and associated factors of COVID-19 vaccine among those living with human immunodeficiency virus, at Bole sub-city health facility Addis Ababa, Ethiopia	87
Comment on the “Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao’an district of She	84
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling	73
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria	73
Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study	73
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies	66
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study	63
Healthcare workers’ and caregivers’ knowledge, perceptions and experiences of the school-based human papillomavirus (HPV) immunization program: A qualitative study in eThekwini District of the KwaZulu	63
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)	62
Determinants of basic childhood vaccination coverage in European and OECD countries	59
Enhancing COVID-19 booster vaccination among the elderly through text message reminders	58
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary	58
Review of the epidemiology, diagnosis and management of invasive meningococcal disease in Vietnam	56
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control	56
Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence	55
Acute encephalitis after COVID-19 vaccination: A case report and literature review	54
Correction	54
Drivers and barriers to influenza vaccination in the post–COVID-19 era in the Federation of Bosnia and Herzegovina: A qualitative study using focus groups with risk groups and in-depth interviews with	51
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector	50
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Asia from 2015 to 2021	48

Bacteriophages as vaccine platforms: Opportunities and challenges in translation	47
PV-10 enhances immune responses in hepatitis B vaccination through STING pathway	46
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children	45
HV&I Reviewer Highlight	41
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents	40
Community based participatory research as a promising practice for addressing vaccine hesitancy, rebuilding trust and addressing health disparities among racial and ethnic minority communities	40
Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak	40
Childhood vaccination uptake among children born in Aotearoa New Zealand based on parental nationality	39
Individual and neighborhood factors associated with being unvaccinated against COVID-19 among pregnant persons	39
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children	39
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain	38
How to make effective HPV vaccine recommendations starting at age 9	38
Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy	36
Associations between vaccination clinic factors and DTaP dropout in China: A cross-sectional study	36
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China	36
The effect of preexisting antibodies from Tdap vaccination during pregnancy on infant antibody responses to the pertussis-containing vaccines	36
Acceptability of patient-centered digital vaccine safety monitoring: A Canadian Immunization Research Network study	35
Age- and time-dependent waning vaccine effectiveness of PPV23 against community-acquired pneumonia among adults aged 60 and older: A cohort study	35
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges	34
A cross-sectional study assessing Pro-VC-Be short-form questionnaire in Canada; measuring psychosocial determinants of vaccination behavior in Canadian healthcare professionals	34
A Bayesian re-analysis of the DANFLU-1 trial	34
A novel anti-PcrV monoclonal antibody inhibits toxin-mediated cytotoxicity and enhances survival in mouse models of Pseudomonas aeruginosa infection	33
Pharmacovigilance assessment of adverse events following yellow fever vaccination: Disproportionality analysis of VAERS reports, 2015–2025	33
Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines	33
Single-cell analysis unravels the role of NK cells and monocytes in the control of SARS-CoV-2 breakthrough infections in vaccinated individuals	32
Medical students’ knowledge about human papillomavirus (HPV), HPV vaccine and head and neck cancer	32
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance	32
Factors associated with willingness to accept pneumococcal vaccine based on the Health Belief Model among the elderly (≥60 years) living in Klang Valley, Malaysia	32
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children	32
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention	32
Improving Tdap maternal immunization rate in Saudi Arabia	32
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study	32
Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer	31
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have	31
Pertactin deficiency of Bordetella pertussis : Insights into epidemiology, and perspectives on surveillance and public health impact	31
Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies	31
HV&I Reviewer Highlight	31
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature	31
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China	30
“Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials”	30
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix?	30
Adverse events after COVID-19 vaccination self-reported by healthcare workers are reliable	30
Determinants of immunization defaulters among children aged 12–23 months in Ambo town, Oromia, Ethiopia: A case–control study	30
Analysis on the characteristics of delayed EV71 vaccination among children in the birth cohort from 2017 to 2022	29
Impact of immunization strategies, public health and social measures on the incidence of varicella among children aged 0–14 years in Quzhou City	29
COVID-19 vaccine hesitancy between teachers and students in a college, a cross-sectional study in China	29
Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019	29
Vaccine confidence and information sources among children and adolescents: A national cross-sectional survey	29
Vaccine literacy among Italian travelers: A web-based survey using a brief assessment tool	29
Attitudes and behavior of medical students toward receiving the COVID-19 vaccine	29

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis	28
A review of technological developments in lipid nanoparticle application for mRNA vaccination	28
An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination	28
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults	28
Disparities in full immunization coverage among urban and rural children aged 12-23 months in southwest Ethiopia: A comparative cross-sectional study	28
Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus	27
Integrating the CARD (Comfort Ask Relax Distract) system in a mass vaccination clinic to improve the experience of individuals during COVID-19 vaccination: a pre-post implementation study	27
The role of age, sex, and ethnicity in vaccine trust, and sources of information in Canada: Findings from a national survey	27
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy	27
Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or old	27
State of pneumococcal vaccine immunity	26
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional study	26
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis	26
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized control	26
Validation of self-reported human papillomavirus vaccination in young adult men who have sex with men	26
Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China	26
Another measles outbreak in the Philippines? The essentiality of a successful vaccination program and public cooperation	25
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States	25
RSV disease in infants and young children: Can we see a brighter future?	25
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years	25
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)	25
Exploring mother-daughter communication and social media influence on HPV vaccine refusal for daughters aged 9-17 years in a cross-sectional survey of 11,728 mothers in China	25
The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer	24
Development of a herpes zoster vaccination intention scale and identification of factors associated with vaccine hesitancy among middle-aged and older attendees in community health centers: A Protecti	24
Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis	23
CEA vaccines	23
Human Papillomavirus vaccine knowledge and recommendation practice among primary care providers, Almaty, Kazakhstan – 2023	23
BC02-adjuvanted varicella-zoster virus glycoprotein E subunit vaccine overcomes immunosenescence to induce robust neutralizing antibodies and multifunctional T-cell immunity in seropositive aged murin	23
Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword	23
Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review	23
Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer	23
Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia	23
COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study	23
Statistical and machine learning methods for immunoprofiling based on single-cell data	23
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial	23
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors	23
Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City	22
Safety and immunogenicity of full-dose quadrivalent influenza vaccine in children 6–35 months of age in China: A randomized, double-blind, clinical trial	22
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)	22
Influenza vaccination landscape in Italy: A comprehensive study through the OBVIOUS project lens	22
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine	22
Access to a protected setting vaccination for allergic patients: Evaluation of appropriateness. The experience of Bari Policlinico University Hospital	22
The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis	22
“They were saying that it’s the end of the world”: Experiences of COVID-19 and beliefs about the COVID-19 vaccine among refugees in Rhode Island, US	22
Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China	21
Autologous engineered T cell receptor therapy in advanced cancer	21
Public health impact of herpes zoster vaccination on older adults in Hong Kong	21
HV&I reviewer highlight	21
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers	21
Human vaccines and immunotherapeutics: News July 2025	21
Understanding the impact process of vaccine adoption for COVID-19	21
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2	21
Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer	21
Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment	21
Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among Central American immigrant parents in the United States	21
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country	21
Multilevel perspectives on school-based opportunities to improve HPV vaccination among medically underserved adolescents: Beyond school entry mandates	21
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale	21
Bibliometric and visual analysis of vaccination hesitancy research from 2013 to 2022	21
A video-based educational intervention to improve vaccine acceptance for Schistosomiasis japonicum: A pre–post study using the 5C model in rural China	21
COVID-19 vaccine acceptance rate and its predictors in Ethiopia: A systematic review and meta-analysis	20
Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohor	20
2024 List of Reviewers	20
Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report	20
Response to Letter to the Editor by Amnuay Kleebayoon, Viroj Wiwanitkit titled: Hesitancy toward vaccination against COVID-19	20
COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study	20
Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy	20
Comment on “Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study”	20
Is vaccine hesitancy related to mental health after the adjustment of the zero-COVID-19 strategy in the elderly? A mediation analysis in China	20
Cost-effectiveness of a behavioral insights-informed digital campaign to increase HPV vaccination in Bangladesh	19
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period	19
Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity	19
Vaccine hesitancy and its determinants among refugee parents resettled in Aotearoa New Zealand	19
Changes in 23-valent pneumococcal polysaccharide vaccination rate and associated factors in 2022 and 2024 among community-based older adults in Shanghai, China	19
Safety Surveillance for Hepatitis A Vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database	19
The attitude and knowledge of pediatricians and family physicians toward COVID-19 vaccination in children: A cross-sectional study	19
Spatiotemporal distribution and determinants of immunization among children aged 12–23 months in Ethiopia: Using EDHS 2000, 2005, 2011, and 2016	19
Lessons learned from 2 years of influenza vaccinations in the UK and USA during the COVID-19 pandemic as respiratory viruses return	19
Comparing factors influencing seasonal influenza vaccine acceptance and intentions among Chinese university students residing in China and UK: A cross-sectional study	19
Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer	19

Survey of pediatricians concerning the human papillomavirus vaccine in Japan: Positive attitudes toward vaccination during the period of proactive recommendation being withheld	19
Development of mRNA rabies vaccines	19
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dos	18
Analysis on willingness and its influencing factors of influenza vaccination among HCWs in Quzhou in 2022–2023 influenza season	18
Seroepidemiological survey of the population 10 years after the implementation of the varicella vaccine 2-dose immunization strategy	18
Exploring nurses’ experiences with a school-located influenza vaccination program: A qualitative study in the region of Murcia, Spain	18
Closer adult child–parent relations the stronger the vaccine hesitancy: A cross-sectional study of adult Children’s attitudes toward pneumococcal vaccination of elderly parents and its determinants in	18
Seasonal influenza vaccination uptake among health and medical college students: A discrete choice experiment	18
Modifying non-coding regions of linear DNA vaccines to explore the interplay of expression and inflammation in immunogenicity	18
A study on the willingness and influencing factors of non-EPI vaccines recommendations among Chinese vaccination staff under major infectious disease outbreaks	18
Diverse processes in rotavirus vaccine development	18
Mpox vaccination hesitancy and its associated factors among the general population in China: A national observational study	18
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial	18
Immunogenicity persistence after four intramuscular triple-dose or standard-dose hepatitis B vaccine in patients receiving methadone maintenance treatment: A 1-year follow-up study in China	18
“Same principles, different decisions”: A qualitative study exploring the attitudes of COVID-19 vaccination among school staff in Switzerland	18
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial	18
A retrospective audit of neonatal BCG vaccination in Grampian, Scotland	18
Human papillomavirus (HPV) vaccine clinical trials: A cross-sectional analysis of clinical trials registries	18
11th Immunotherapy of Cancer conference (ITOC): A meeting report	18
Comparative analysis of immunogenicity between first-dose measles-mumps-rubella (MMR) vaccine administration and combined MMR-rotavirus vaccination	18
Vaccination in the shadow of uncertainty: Exploring the links between government trust and COVID-19 vaccine acceptance	18
Management of MOG antibody-associated disease by pembrolizumab and radiation myelopathy in an elderly patient: A case report and literature review	18
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective	17
A community-wide epidemic of hepatitis A virus genotype IA associated with consumption of shellfish in Yantai, eastern China, January to March 2020	17
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination	17
Immunity gap for measles in young adults: Seroprevalence study in blood donors in southern Italy	17
Advancements in the development of nucleic acid vaccines for syphilis prevention and control	17
Transmission patterns of pertussis in school-based clustered outbreaks: A retrospective analysis in Zhejiang Province, China, 2024	17
Correlates of uptake of COVID-19 vaccines and motivation to vaccinate among Malawian adults	17
Comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”	17
Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings	17
Respiratory syncytial virus immunization with nirsevimab: Acceptance and satisfaction assessment in infants and risk groups in the region of Murcia (Spain)	17
A systematic review of gastritis as an immune-related adverse event in clinical interventions	17
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis	17
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study	17
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus	17
Overcoming barriers to HPV vaccination in rural Vermont through a multicomponent peer-based approach	17
Pneumonia hospitalizations of children aged <2 years in Poland before (2013–2016) and after (2017–2018) universal mass vaccination with 10-valent pneumococcal non-typeable Haemophilu	17
The research status and prospects of MUC1 in immunology	16
Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis”	16
Enhancing routine immunization efforts for older adults and frail individuals: Good practices during the SARS-CoV-2 pandemic in Italy	16
Mothers’ perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds	16
Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner	16
Immunogenicity and safety of the non-typable Haemophilus influenzae – Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the	16
Review of bimekizumab in the treatment of psoriasis	16
Establishment of the 1st Chinese national standard for CA6 neutralizing antibody	16
Correction	16
Human vaccines & immunotherapeutics: News March 2023	16
Human vaccines & immunotherapeutics: News December 2022	16
Effectiveness of cocoon strategy vaccination on prevention of influenza-like illness in young infants	16
The progress of peptide vaccine clinical trials in gynecologic oncology	16
Cost-effectiveness and epidemiological impact of gender-neutral HPV vaccination in Spain	16
Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy	16
Navigating vaccine hesitancy: Strategies and dynamics in healthcare professional-parent communication	16
Misinformation and COVID-19 vaccine uptake hesitancy among frontline workers in Tanzania: Do demographic variables matter?	16
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects	16
COVID-19 vaccination up-take in three districts of Nepal	16
Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines	16
Determinants of parental self-reported uptake of influenza vaccination in preschool children during the COVID-19 pandemic	16
Economic burden of respiratory syncytial virus disease in Latin America: A systematic review	16
Parental intention to vaccinate adolescents with HPV vaccine in selected communities in Ibadan, Southwest Nigeria: an application of Integrated Behavioral Model	16
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2	16
Outbreak report of rotavirus gastroenteritis among remotely vaccinated travelers: A potential implication of booster vaccine for travelers to endemic countries	15
Protein nanocages: A new frontier in mucosal vaccine delivery and immune activation	15
Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated	15
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis	15
Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges	15
Documented vaccination as proof of immunity compared to serology in medical students	15
Natural carrier systems in cancer vaccines and immunotherapy	15
The safety and immunogenicity of inactivated rotavirus vaccine delivered by a dissolving microneedle patch in rats	15
Parents’ preference for the inclusion of pediatric vaccines in the Chinese National Immunization Program: A discrete choice experiment	15
Association between depression and three key COVID-19-related outcomes: The SHARE study	15
Efficacy and safety analysis of immune checkpoint inhibitor rechallenge in advanced esophageal squamous cell carcinoma: A retrospective study	15
Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22	15
Systematic literature review and meta-analysis on the prevalence of rotavirus genotypes in Europe and the Middle East in the post-licensure period	15
Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse events	15
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan	15
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases	15
COVID-19 vaccine hesitancy among Latinx individuals in North Texas: Understandings from a community study	15
Anti-inflammatory effects of immunotherapy in clinical treatment and its potential mechanism in alleviating sleeping disorders: A systematic bibliometric study	15
Rubella immunization policy in Japan: Immunity gaps arising from program differences and inconsistent cutoff standards	15
Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-2022	15
Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis	15
The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance	15
Parents’ willingness to vaccinate their daughters with human papillomavirus vaccine and associated factors in Debretabor town, Northwest Ethiopia: A community-based cross-sectional study	15
Clinical and economic burden of herpes zoster in Mexico: A retrospective medical chart analysis in a private healthcare setting	15
Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot	15
Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review	14
Impact of a focus education in Zoom on COVID-19 vaccine hesitancy in Hong Kong parents of the preschoolers	14
Public attitudes on social media toward vaccination before and during the COVID-19 pandemic	14
Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’	14
Response to comment on ‘Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study’	14
Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration	14
Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States	14
Safety of the 15-valent pneumococcal conjugate vaccine: A phase I clinical trial	14